Biotechnology Companies By Beta

Beta
BetaEfficiencyMarket RiskExp Return
1CUBT Curative Biotechnology
214.95
 0.04 
 15.19 
 0.57 
2PRTG Portage Biotech
99.48
 0.07 
 23.89 
 1.56 
3BRTX BioRestorative Therapies
62.82
(0.10)
 2.96 
(0.30)
4ERNA Eterna Therapeutics
7.77
(0.28)
 7.73 
(2.15)
5MDCX Medicus Pharma Ltd
5.96
 0.13 
 28.55 
 3.79 
6APVO Aptevo Therapeutics
5.07
 0.02 
 13.21 
 0.24 
7CELZ Creative Medical Technology
5.03
(0.04)
 7.13 
(0.31)
8CDIOW Cardio Diagnostics Holdings
4.68
 0.19 
 22.36 
 4.16 
9CDIO Cardio Diagnostics Holdings
4.68
 0.19 
 15.02 
 2.84 
10BHVN Biohaven Pharmaceutical Holding
4.12
(0.03)
 4.07 
(0.10)
11CAPR Capricor Therapeutics
4.02
 0.17 
 12.09 
 2.07 
12OCGN Ocugen Inc
3.77
(0.10)
 3.91 
(0.39)
13ONCO Onconetix
3.73
(0.17)
 14.37 
(2.48)
14JANX Janux Therapeutics
3.52
 0.07 
 7.07 
 0.47 
15VANI Vivani Medical
3.52
 0.01 
 3.11 
 0.02 
16CRIS Curis Inc
3.35
(0.25)
 3.58 
(0.90)
17GLSI Greenwich Lifesciences
3.32
(0.05)
 3.06 
(0.17)
18CHHL China Holdings
3.25
 0.00 
 0.00 
 0.00 
19CLLS Cellectis SA
3.2
(0.12)
 3.17 
(0.39)
20FHTX Foghorn Therapeutics
3.15
(0.22)
 4.57 
(1.02)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time. In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.